More major bleeds with warfarin than NOACs

In patients with atrial fibrillation (AF), warfarin therapy carries a higher risk of major bleeds than use of a non-vitamin K antagonist oral anticoagulant (NOAC), a Tasmanian study shows.

The study followed 2200 patients on antithrombotic therapy for AF who were admitted to the Royal Hobart Hospital between January 2011 and July 2015.